MedTrace Logo

Electronic Warning System for Atrial Fibrillation

NCT02455102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1707

Last updated 2015-12-22

No results posted yet for this study

Summary

The aim of this randomized controlled study is to evaluate whether a newly designed electronic warning system will increase the initiation rate of adequate stroke preventive measures in patients with atrial fibrillation.

Conditions

Interventions

OTHER

Electronic warning alert

A newly-installed warning system for stroke prevention in atrial fibrillation.

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Nils Kucher, Prof. M.D. · Department of Angiology, Swiss Cardiovascular Center, University of Berne

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02455102 on ClinicalTrials.gov